id	domain	url
admet-184	www.clinicaltrials.gov	www.clinicaltrials.gov)
admet-184	www.clinicaltrials.gov	http://www.clinicaltrials.gov
admet-184	www.who.int	http://www.who.int/mental_health/neurology/neurodiso/en/index.html
admet-184	www.who.int	http://www.who.int/mental_health/neurology/neurodiso/en/index.html
admet-184	www.clinicaltrials.gov	http://www.clinicaltrials.gov/ct2/show/results/nct01145482
admet-184	www.kurvetech.com	http://www.kurvetech.com/pdf/depositioncomp_scintigraphicstudy.pdf
admet-184	www.clinicaltrials.gov	http://www.clinicaltrials.gov/ct2/show/results/nct01145482
admet-184	www.kurvetech.com	http://www.kurvetech.com/pdf/depositioncomp_scintigraphicstudy.pdf
admet-184	www.bloomberg.com	http://www.bloomberg.com/apps/news?pid=newsarchive&sid=af8dtg4w0xt4
admet-184	snbl.com	http://snbl.com/press-release/licensing-agreement-for-nasaldrug-delivery-technology-platform-nasal-dihydroergotamine-for-treatment-of-migraine-headache
admet-184	www.criticalpharmaceuticals.com	http://www.criticalpharmaceuticals.com/technology/criticalsorb
admet-184	creativecommons.org	http://creativecommons.org/licenses/by/3.0/
admet-184	www.bloomberg.com	http://www.bloomberg.com/apps/news?pid=newsarchive&sid=af8dtg4w0xt4
admet-184	snbl.com	http://snbl.com/press-release/licensing-agreement-for-nasal-drug-delivery-technology-platform-nasal-dihydroergotamine-for-treatment-of-migraine-headache
admet-184	snbl.com	http://snbl.com/press-release/licensing-agreement-for-nasal-drug-delivery-technology-platform-nasal-dihydroergotamine-for-treatment-of-migraine-headache
admet-184	www.criticalpharmaceuticals.com	http://www.criticalpharmaceuticals.com/technology/criticalsorb
admet-184	creativecommons.org	http://creativecommons.org/licenses/by/3.0